Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
Survival rates for metastatic lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), are poor with 5-year survivals of less than 5%. The immune system has an intricate and complex relationship with tumorigenesis; a groundswell of research on the immune system is...
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
China Anti-Cancer Association
2015-06-01
|
| Σειρά: | Cancer Biology & Medicine |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.cancerbiomed.org/index.php/cocr/article/view/844 |